Genworth Financial appoints John Nichols to its Board as new Independent Director

– USA, VA – Genworth Financial, Inc. (NYSE: GNW), announced the election of all nine directors nominated at its 2016 annual meeting of stockholders today. The board members re-elected were William H. Bolinder, G. Kent Conrad, Melina E. Higgins, Thomas J. McInerney, David M. Moffett, Thomas E. Moloney, James A. Parke, and James S. Riepe, while John R. Nichols was elected today as a new independent director. Nichols, 54, served as Executive Vice President and Chief Risk Officer of the Federal National Mortgage Association from August 2011 until August 2015.

“Genworth would like to recognize two directors who are leaving our Board of Directors – Nancy Karch and Chris Mead,” said James S. Riepe, Genworth non-executive chairman of the board. “Ms. Karch joined the board in 2005, while Ms. Mead joined our board in 2009. Their continued and unyielding commitment to Genworth have been invaluable, and we are grateful for all of their efforts on behalf of our Company.”

At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and ratified the selection of KPMG LLP as Genworth’s independent registered public accounting firm for 2016.

About Genworth Financial

Genworth Financial, Inc. (NYSE: GNW) is a Fortune 500 insurance holding company committed to helping families achieve the dream of homeownership and address the financial challenges of aging through its leadership positions in mortgage insurance and long term care insurance. Headquartered in Richmond, Virginia, Genworth traces its roots back to 1871 and became a public company in 2004.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>